Fusako Nishigaki

1.2k total citations
41 papers, 1.0k citations indexed

About

Fusako Nishigaki is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fusako Nishigaki has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Fusako Nishigaki's work include Protease and Inhibitor Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Fusako Nishigaki is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Fusako Nishigaki collaborates with scholars based in Japan and United States. Fusako Nishigaki's co-authors include Toshitaka Manda, Kyoichi Shimomura, Ikuo Kawamura, Sanae Matsumoto, Y. Ohkubo, Sueo Mukumoto, Toshio Goto, Hirotsugu Ueda, Shozo Sakuma and Seitaro Mutoh and has published in prestigious journals such as Cancer Research, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Fusako Nishigaki

40 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fusako Nishigaki Japan 19 469 208 183 159 141 41 1.0k
Hisao Fukumoto Japan 17 587 1.3× 62 0.3× 432 2.4× 119 0.7× 53 0.4× 30 1.0k
Masamichi Inami Japan 17 331 0.7× 81 0.4× 173 0.9× 118 0.7× 472 3.3× 41 1.0k
Haojian Zhang China 16 662 1.4× 89 0.4× 168 0.9× 52 0.3× 119 0.8× 49 1.2k
Darren C. Phillips United States 16 658 1.4× 77 0.4× 210 1.1× 36 0.2× 206 1.5× 40 1.1k
Dae‐Kee Kim South Korea 27 982 2.1× 53 0.3× 640 3.5× 374 2.4× 160 1.1× 68 1.8k
Peter Norman United Kingdom 18 436 0.9× 135 0.6× 202 1.1× 138 0.9× 301 2.1× 100 1.3k
Denise K. Oelschlager United States 20 602 1.3× 95 0.5× 325 1.8× 26 0.2× 96 0.7× 41 1.2k
Qun Zhou China 18 598 1.3× 54 0.3× 297 1.6× 171 1.1× 173 1.2× 36 1.1k
Chaoxin Hu United States 13 434 0.9× 33 0.2× 367 2.0× 50 0.3× 97 0.7× 18 920
K. V. Honn United States 23 728 1.6× 52 0.3× 338 1.8× 114 0.7× 90 0.6× 34 1.7k

Countries citing papers authored by Fusako Nishigaki

Since Specialization
Citations

This map shows the geographic impact of Fusako Nishigaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fusako Nishigaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fusako Nishigaki more than expected).

Fields of papers citing papers by Fusako Nishigaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fusako Nishigaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fusako Nishigaki. The network helps show where Fusako Nishigaki may publish in the future.

Co-authorship network of co-authors of Fusako Nishigaki

This figure shows the co-authorship network connecting the top 25 collaborators of Fusako Nishigaki. A scholar is included among the top collaborators of Fusako Nishigaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fusako Nishigaki. Fusako Nishigaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Seiji, Yoshiko Fujita, Kumiko Goto, et al.. (2024). Abstract 1336: Verification of the effect of human allogeneic iPS cell-derived gene-engineered NK cells (eNK cells HLCN061) on mesothelioma. Cancer Research. 84(6_Supplement). 1336–1336.
2.
Nishigaki, Fusako, et al.. (2017). Human resource development contributes to the creation of outstanding regenerative medicine products. Regenerative Therapy. 7. 17–23. 8 indexed citations
3.
Ishikawa, Takeshi, Fusako Nishigaki, Susumu Miyata, et al.. (2004). Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. British Journal of Pharmacology. 144(1). 133–143. 49 indexed citations
4.
Nishigaki, Fusako, Tatsuya Sasakawa, T Ogawa, et al.. (2003). Anti-arthritic properties of FK506 on collagen-induced arthritis in rats. Inflammation Research. 52(12). 524–529. 32 indexed citations
5.
Kamitakahara, Hiroshi, et al.. (2002). Sulfated glycofuranans as inhibitors of melanoma lung metastasis. Journal of Wood Science. 48(3). 204–209. 3 indexed citations
6.
Inami, Masamichi, Ikuo Kawamura, Susumu Tsujimoto, et al.. (2002). Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma. Cancer Letters. 181(1). 39–45. 15 indexed citations
7.
Sakuma, Shozo, Fusako Nishigaki, T Ogawa, et al.. (2001). FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflammation Research. 50(10). 509–514. 43 indexed citations
8.
Tsujimoto, Susumu, Ikuo Kawamura, Masamichi Inami, et al.. (2000). Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.. PubMed. 20(5A). 3111–6. 10 indexed citations
9.
Sakuma, Shozo, Yasuko Kato, Fusako Nishigaki, et al.. (2000). FK506 potently inhibits T cell activation induced TNF‐α and IL‐1β production in vitro by human peripheral blood mononuclear cells. British Journal of Pharmacology. 130(7). 1655–1663. 84 indexed citations
10.
Kawamura, Ikuo, Elizabeth P. Lacey, N. Yamamoto, et al.. (2000). Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.. PubMed. 19(5B). 4105–11. 13 indexed citations
11.
Tsuji, Kiyoshi, et al.. (1998). Synthesis and effects of novel thiazole derivatives against thrombocytopenia. Bioorganic & Medicinal Chemistry Letters. 8(18). 2473–2478. 6 indexed citations
12.
Naoe, Yoshinori, Masamichi Inami, Ikuo Kawamura, et al.. (1998). Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity. Japanese Journal of Cancer Research. 89(6). 666–672. 22 indexed citations
13.
Naoe, Yoshinori, Masamichi Inami, Fusako Nishigaki, et al.. (1998). FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome. Cancer Chemotherapy and Pharmacology. 42(1). 31–36. 38 indexed citations
14.
Ogino, Takashi, Kiyoshi Tsuji, Takashi Tojo, et al.. (1998). Discovery of FR115092 : A novel antinephritic agent. Bioorganic & Medicinal Chemistry Letters. 8(1). 75–80. 6 indexed citations
15.
Naoe, Yoshinori, Masamichi Inami, Sanae Matsumoto, et al.. (1998). Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro. Japanese Journal of Cancer Research. 89(10). 1047–1054. 16 indexed citations
16.
Yamamoto, N., Ikuo Kawamura, Fusako Nishigaki, et al.. (1998). Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.. PubMed. 18(1A). 139–44. 18 indexed citations
17.
Kawamura, Ikuo, Elizabeth P. Lacey, Fusako Nishigaki, et al.. (1995). A New Aromatase Inhibitor, FR901537. II. Pharmacological and Antitumor Effects.. The Journal of Antibiotics. 48(8). 763–767. 2 indexed citations
18.
Maeda, Masahiro, Shingo Suzuki, Susumu Satoh, et al.. (1994). The Induction of Interleukin-6(IL-6) and Colony-Stimulating Factors(CSFs) by FK565 and Its Thrombopoietic Activity Following in Vivo Administration.. Biological and Pharmaceutical Bulletin. 17(2). 173–179. 4 indexed citations
19.
Manda, Toshitaka, et al.. (1990). The efficacy of combined treatment with recombinant human tumor necrosis factor-α and 5-fluorouracil is dependent on the development of capillaries in tumor. European Journal of Cancer and Clinical Oncology. 26(2). 93–99. 11 indexed citations
20.
Kawamura, Ikuo, Sueo Mukumoto, Toshitaka Manda, et al.. (1989). Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.. PubMed. 39(8). 889–93. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Masamichi Inami Breakdown of academic impact, for papers by Haojian Zhang Breakdown of academic impact, for papers by Darren C. Phillips Breakdown of academic impact, for papers by Dae‐Kee Kim Breakdown of academic impact, for papers by Peter Norman Breakdown of academic impact, for papers by Denise K. Oelschlager Breakdown of academic impact, for papers by Qun Zhou Breakdown of academic impact, for papers by Chaoxin Hu Breakdown of academic impact, for papers by K. V. Honn
Rankless by CCL
2026